The Latest
-
Healthcare’s agentic AI boom is outpacing governance: report
Patient safety could be at risk if agentic AI tools are rolled out without proper guardrails, Imprivata’s chief medical and growth officer warns.
-
FDA clears vessel-sealing device for Medtronic’s Hugo robot
Widely adopted in open and laparoscopic surgeries, the LigaSure instrument is now available for use with the Hugo robotic system.
-
Cyberattacks have plagued the medtech industry in 2026
Stryker, Boston Scientific, Medtronic and Abbott are among the medtech firms that have disclosed cyberattacks this year. Check out MedTech Dive’s roundup of coverage for the latest cybersecurity news.
Updated Sept. 17, 2026 -
J&J sells Laminar LAA closure assets it bought 3 years ago
The decision is part of J&J’s strategy to prioritize resources for the greatest impact and positions Laminar for success under dedicated ownership, a spokesperson said.
-
Dexcom gives CFO Jereme Sylvain expanded role
Sylvain will work as chief operating officer of the diabetes technology company while continuing as its CFO.
-
CMS expands ACCESS pilot to boost use of digital health tech
The CMS is expanding the number of covered conditions under the program to include heart failure, COPD, substance use disorders and tobacco cessation.
-
Intuitive single-port robot earns CE mark for new indication
Gaining authorization for transvaginal gynecologic procedures expands the list of indications for da Vinci SP in Europe.
-
Beta Bionics’ insulin patch pump gets FDA nod
By bringing its first patch pump to market, Beta Bionics will be able to compete with industry leader Insulet.
-
OIG urges crackdown on equipment suppliers in Medicare Advantage
The agency says the CMS and MA organizations aren’t doing enough to screen durable medical equipment providers, especially out-of-network companies that aren’t enrolled in Medicare.
-
Zimmer proposes to cut 580 jobs in Switzerland
Reducing headcount at the Swiss site is part of an ongoing effort to simplify the company’s manufacturing footprint and supply chain.
-
Medtronic begins final steps to separate MiniMed
The separation will allow Medtronic to focus on its cardiovascular, neuroscience and surgical portfolios, CEO Geoff Martha said.
-
CMS expands TAVR Medicare coverage to asymptomatic patients
The Centers for Medicare and Medicaid Services’ policy update extends Medicare coverage to severe aortic stenosis patients without symptoms, a change that analysts said will especially benefit Edwards Lifesciences.
-
Boston Scientific fully restores operations after cyberattack
CEO Mike Mahoney gave more details at a Thursday investor conference, saying the company likely lost orders while its plants and distribution centers were shut down.
-
ARPA-H to award $62.7M for AI in cardiovascular care
Companies including Tempus AI and Updoc are tasked with building an agentic AI system for managing heart failure.
-
STAAR Surgical hires former CEO to lead commercial team
David Bailey has rejoined STAAR after participating in the successful campaign to block Alcon’s takeover of the company.
-
Axogen to buy BioCircuit Technologies for $200M
Analysts called the acquisition a good fit for Axogen but said the company’s plans to finance the deal with a public stock offering could be a point of contention for investors.
-
Stryker stock falls on slower peripheral vascular, hip sales
CFO Preston Wells said at a healthcare conference that the company is still working through supply issues in its peripheral vascular business and had fewer hip sales than expected so far this quarter.
-
Deep Dive
4 questions about the FDA’s approach to generative AI
The medtech industry is awaiting FDA guidance on generative AI. The agency has sought feedback in advisory meetings and a discussion paper as the technology becomes more prevalent.